Mold_5_0	2	1924	1.548755e-53 
Mold_12_0	1	2626	0.996449


(Melanoma CyTOF ICI -- after re-curation):


Singles
-------
On average, the fraction of cells that are Naive cytotoxic T cells is 2.29 times higher in cohort 1 than in cohort 2.
On average, the fraction of cells that are T regulatory cellss is 1.54 times higher in cohort 1 than in cohort 2.

Doubles
-------
# Based on B cell

On average, the ratio of the number of cells that are B cellss to those that are Endothelial stroma is 8.61 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are B cellss is 24.25 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are B cellss to those that are Lineage including macrophage is 3.14 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are B cellss is 23.04 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are B cellss to those that are Lineage including monocyte is 3.04 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including monocyte to those that are B cellss is 17.63 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are B cellss to those that are Melanoma is 4.25 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Melanoma to those that are B cellss is 12.11 times higher in cohort 2 than in cohort 1.

## Consistent...
On average, the ratio of the number of cells that are B cellss to those that are Naive cytotoxic T cells is 2.99 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are B cellss is 1.84 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are B cellss to those that are Naive T helper cells is 1.81 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Naive T helper cells to those that are B cellss is 8.58 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are B cellss to those that are T regulatory cellss is 30.47 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are T regulatory cellss to those that are B cellss is 2.08 times higher in cohort 1 than in cohort 2.


# Based on Cytotoxic T cell antigen-experienced

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are Endothelial stroma is 6.47 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are Cytotoxic T cells antigen-experienced is 3.15 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are Lineage including macrophage is 22.88 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are Cytotoxic T cells antigen-experienced is 3.36 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are Lineage including monocyte is 41.24 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including monocyte to those that are Cytotoxic T cells antigen-experienced is 2.35 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are Naive T helper cells is 9.78 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Naive T helper cells to those that are Cytotoxic T cells antigen-experienced is 1.32 times higher in cohort 2 than in cohort 1.

## Consistent but weak...
On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are Melanoma is 2.92 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Melanoma to those that are Cytotoxic T cells antigen-experienced is 1.09 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are T regulatory cellss is 2.15 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are T regulatory cellss to those that are Cytotoxic T cells antigen-experienced is 1.02 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are T cellss is 1.33 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are T cellss to those that are Cytotoxic T cells antigen-experienced is 1.32 times higher in cohort 1 than in cohort 2.

## Consistent and stronger
On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are Naive cytotoxic T cells is 3.21 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Cytotoxic T cells antigen-experienced is 1.81 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are T helper cells antigen-experienced is 4.54 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are T helper cells antigen-experienced to those that are Cytotoxic T cells antigen-experienced is 1.18 times higher in cohort 1 than in cohort 2.


# Based on Endothelial stroma

On average, the ratio of the number of cells that are T cellss to those that are Endothelial stroma is 9.16 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are T cellss is 1.46 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are T helper cells to those that are Endothelial stroma is 8.21 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are T helper cells is 1.65 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are T helper cells antigen-experienced to those that are Endothelial stroma is 11.41 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are T helper cells antigen-experienced is 1.06 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are T regulatory cellss to those that are Endothelial stroma is 23.60 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are T regulatory cellss is 4.85 times higher in cohort 1 than in cohort 2.

## Consistent and strong but imbalanced...
On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Endothelial stroma is 58.63 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are Naive cytotoxic T cells is 1.21 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are Naive T helper cells to those that are Endothelial stroma is 11.54 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Endothelial stroma to those that are Naive T helper cells is 1.62 times higher in cohort 2 than in cohort 1.

## Consistent and strong
On average, the ratio of the number of cells that are Endothelial stroma to those that are Melanoma is 6.70 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Melanoma to those that are Endothelial stroma is 8.09 times higher in cohort 2 than in cohort 1.


# Based on Lineage including macrophage

## Consistent but weak
On average, the ratio of the number of cells that are Naive T helper cells to those that are Lineage including macrophage is 4.73 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are Naive T helper cells is 1.88 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are T helper cells antigen-experienced to those that are Lineage including macrophage is 5.91 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are T helper cells antigen-experienced is 1.49 times higher in cohort 2 than in cohort 1.

## Consistent and strong
On average, the ratio of the number of cells that are Melanoma to those that are Lineage including macrophage is 6.78 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are Melanoma is 2.69 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Lineage including macrophage is 338.32 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are Naive cytotoxic T cells is 2.04 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are T cellss to those that are Lineage including macrophage is 30.49 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are T cellss is 1.75 times higher in cohort 2 than in cohort 1.


# Based on Lineage including monocyte

## Consistent and strong but imbalanced
On average, the ratio of the number of cells that are T cellss to those that are Lineage including monocyte is 49.31 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including monocyte to those that are T cellss is 1.81 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are T helper cells antigen-experienced to those that are Lineage including monocyte is 6.99 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including monocyte to those that are T helper cells antigen-experienced is 1.61 times higher in cohort 2 than in cohort 1.

## Consistent and strong
On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Lineage including monocyte is 201.59 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including monocyte to those that are Naive cytotoxic T cells is 2.14 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are Melanoma to those that are Lineage including monocyte is 6.70 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Lineage including monocyte to those that are Melanoma is 2.96 times higher in cohort 1 than in cohort 2.


# Based on Melanoma

## Consistent but weaker
On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Melanoma is 2.23 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Melanoma to those that are Naive cytotoxic T cells is 6.67 times higher in cohort 2 than in cohort 1.

## Consistent but imbalanced
On average, the ratio of the number of cells that are T regulatory cellss to those that are Melanoma is 1.53 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Melanoma to those that are T regulatory cellss is 33.19 times higher in cohort 2 than in cohort 1.

## Consistent and strong
On average, the ratio of the number of cells that are Naive T helper cells to those that are Melanoma is 2.32 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Melanoma to those that are Naive T helper cells is 77.84 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are T helper cells antigen-experienced to those that are Melanoma is 3.81 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Melanoma to those that are T helper cells antigen-experienced is 25.20 times higher in cohort 2 than in cohort 1.


# Based on Naive cytotoxic T Cell
weak


# Based on Naive T helper cell

## Consistent but weak
On average, the ratio of the number of cells that are T regulatory cellss to those that are Naive T helper cells is 1.25 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Naive T helper cells to those that are T regulatory cellss is 6.62 times higher in cohort 2 than in cohort 1.


# Based on T cells
weak


# Based on T helper cell
weak


# Based on T helper experienced
## Consistent but weak
On average, the ratio of the number of cells that are T regulatory cellss to those that are T helper cells antigen-experienced is 1.52 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are T helper cells antigen-experienced to those that are T regulatory cellss is 3.66 times higher in cohort 2 than in cohort 1.



Strongest (ratios):

## Interplay of cytotoxic vs helper and experienced vs not

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are Naive cytotoxic T cells is 3.21 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Cytotoxic T cells antigen-experienced is 1.81 times higher in cohort 1 than in cohort 2.
(Sort of poor p-value)

On average, the ratio of the number of cells that are Cytotoxic T cells antigen-experienced to those that are T helper cells antigen-experienced is 4.54 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are T helper cells antigen-experienced to those that are Cytotoxic T cells antigen-experienced is 1.18 times higher in cohort 1 than in cohort 2.
(Poor p-values)

## Involving monocytes or macrophages compared with some kind of T cells

On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Lineage including macrophage is 338.32 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are Naive cytotoxic T cells is 2.04 times higher in cohort 2 than in cohort 1.
(Poor p-values)

On average, the ratio of the number of cells that are T cellss to those that are Lineage including macrophage is 30.49 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including macrophage to those that are T cellss is 1.75 times higher in cohort 2 than in cohort 1.
(Poor p-values)

On average, the ratio of the number of cells that are Naive cytotoxic T cells to those that are Lineage including monocyte is 201.59 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Lineage including monocyte to those that are Naive cytotoxic T cells is 2.14 times higher in cohort 2 than in cohort 1.
(Poor p-values)

## Isolated type
On average, the ratio of the number of cells that are B cellss to those that are T regulatory cellss is 30.47 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are T regulatory cellss to those that are B cellss is 2.08 times higher in cohort 1 than in cohort 2.
(Poor p-values)

## Isolated explanation ... more vascularization probably
On average, the ratio of the number of cells that are Endothelial stroma to those that are Melanoma is 6.70 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Melanoma to those that are Endothelial stroma is 8.09 times higher in cohort 2 than in cohort 1.
(Poor p-values)



Doubles, intersection then ratio
--------------------------------

On average, the ratio of the number of cells that are Lineage including macrophage and B cellss to those that are Naive cytotoxic T cells is 3.21 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Lineage including monocyte and B cellss to those that are Naive cytotoxic T cells is 3.73 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are Naive T helper cells and B cells to those that are Naive cytotoxic T cells is 4.08 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are Naive T helper cells and B cells to those that are T regulatory cellss is 34.96 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are T helper cells antigen-experienced and B cells to those that are Naive cytotoxic T cells is 3.44 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are T helper cells antigen-experienced and B cells to those that are T regulatory cellss is 24.75 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are Naive cytotoxic T cells and Cytotoxic T cell antigen-experienced to those that are Lineage including monocyte is 201.55 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are Naive cytotoxic T cells and Cytotoxic T cell antigen-experienced to those that are Lineage including macrophage is 269.05 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are Lineage including monocyte and Lineage including macrophage to those that are B cellss is 31.80 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are T helper cells antigen-experienced and Naive T helper cell to those that are T regulatory cellss is 3.95 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are T helper cells antigen-experienced and Naive T helper cell to those that are Lineage including macrophage is 5.56 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are T helper cells antigen-experienced and Naive T helper cell to those that are Lineage including monocyte is 7.75 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are T regulatory cellss and T helper cell antigen-experienced to those that are Lineage including monocyte is 95.74 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are T regulatory cellss and T helper cell antigen-experienced to those that are Lineage including macrophage is 87.68 times higher in cohort 1 than in cohort 2.

None statistically significant.

Doubles intersection of single channels
---------------------------------------
Nothing clear

Single channel pair proximity/etc.
----------------------------------
The average value of the neighborhood enrichment score for phenotype(s) VISTA+, S100+ is 5.26 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) COL1+, PDL1+ is 2.44 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) CD45RO+, CD45RA+ is 6.15 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) H3+, HLA-DR+ is 5209.13 times higher in cohort 2 than in cohort 1.

The average value of the proximity score for phenotype(s) CD40+, CD16+ is 1.21 times higher in cohort 1 than in cohort 2.
The average value of the proximity score for phenotype(s) CD40+, CD31+ is 1.24 times higher in cohort 1 than in cohort 2.
The average value of the proximity score for phenotype(s) CD40+, CD29+ is 1.29 times higher in cohort 1 than in cohort 2.
The average value of the proximity score for phenotype(s) HLA-DR+, CD45RO+ is 1.14 times higher in cohort 1 than in cohort 2.

The average value of the neighborhood enrichment score for phenotype(s) HLA-DR+, CD45RO+ is 12575.69 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) HLA-DR+, CD45RA+ is 276.76 times higher in cohort 1 than in cohort 2.

The average value of the neighborhood enrichment score for phenotype(s) CD40+, CD45+ is 6.27 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) CD40+, CD29+ is 2.27 times higher in cohort 2 than in cohort 1.

The average value of the neighborhood enrichment score for phenotype(s) CD40+, CD16+ is 1.19 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) CD45+, CD29+ is 2.02 times higher in cohort 2 than in cohort 1.

The average value of the neighborhood enrichment score for phenotype(s) CD45+, CD31+ is 1.61 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) CD29+, CD31+ is 3.70 times higher in cohort 1 than in cohort 2.

The average value of the neighborhood enrichment score for phenotype(s) CD45+, CD16+ is 107.77 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) CD29+, CD16+ is 175.35 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) CD31+, CD16+ is 3.34 times higher in cohort 1 than in cohort 2.

The average value of the neighborhood enrichment score for phenotype(s) CD29+, CD14+ is 92.13 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) S100+, CD14+ is 3.97 times higher in cohort 2 than in cohort 1.
The average value of the co-occurrence score for phenotype(s) S100+, CD14+ is 1.11 times higher in cohort 2 than in cohort 1.


Single channel against itself proximity etc.
--------------------------------------------
The average value of the proximity score for phenotype(s) ICOS+ is 1.26 times higher in cohort 1 than in cohort 2.
The average value of the spatial autocorrelation score for phenotype(s) ICOS+ is 2.37 times higher in cohort 2 than in cohort 1.

The average value of the proximity score for phenotype(s) CD8A+ is 1.28 times higher in cohort 1 than in cohort 2.
The average value of the spatial autocorrelation score for phenotype(s) CD8A+ is 2.71 times higher in cohort 2 than in cohort 1.
(... The average value of the ripley score for phenotype(s) CD8A+ is 1.44 times higher in cohort 1 than in cohort 2.)

The average value of the neighborhood enrichment score for phenotype(s) CD20+ is 2.47 times higher in cohort 1 than in cohort 2.

The average value of the neighborhood enrichment score for phenotype(s) PDL1+ is 7.36 times higher in cohort 2 than in cohort 1.
The average value of the spatial autocorrelation score for phenotype(s) PDL1+ is 14.49 times higher in cohort 2 than in cohort 1.

The average value of the spatial autocorrelation score for phenotype(s) CD45RA+ is 2.10 times higher in cohort 1 than in cohort 2.


Pair channel ratios
-------------------
On average, the ratio of the number of cells that are SMA+ to those that are MEK1/2+ is 95.03 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are MKI67+ to those that are MEK1/2+ is 81.15 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD14+ to those that are MEK1/2+ is 56.78 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are ERK1/2+ to those that are MEK1/2+ is 92.45 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD16+ to those that are MEK1/2+ is 59.14 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD31+ to those that are MEK1/2+ is 64.61 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD29+ to those that are MEK1/2+ is 81.33 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD45+ to those that are MEK1/2+ is 57.65 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD4+ to those that are MEK1/2+ is 61.81 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD68+ to those that are MEK1/2+ is 72.69 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD8A+ to those that are MEK1/2+ is 31.89 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD3+ to those that are MEK1/2+ is 38.38 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD40+ to those that are MEK1/2+ is 44.41 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are SMA+ to those that are pMEK1/2+ is 46.60 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are MEK1/2+ to those that are pMEK1/2+ is 55.77 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are MKI67+ to those that are pMEK1/2+ is 106.81 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD14+ to those that are pMEK1/2+ is 55.27 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are ERK1/2+ to those that are pMEK1/2+ is 47.21 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD16+ to those that are pMEK1/2+ is 64.85 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD31+ to those that are pMEK1/2+ is 43.73 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD29+ to those that are pMEK1/2+ is 46.70 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD45+ to those that are pMEK1/2+ is 39.07 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD4+ to those that are pMEK1/2+ is 56.89 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD68+ to those that are pMEK1/2+ is 72.51 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD8A+ to those that are pMEK1/2+ is 25.70 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are CD3+ to those that are pMEK1/2+ is 36.05 times higher in cohort 1 than in cohort 2.

On average, the ratio of the number of cells that are SMA+ to those that are HLA-DR+ is 100.91 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are MKI67+ to those that are HLA-DR+ is 86.21 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD14+ to those that are HLA-DR+ is 60.01 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are ERK1/2+ to those that are HLA-DR+ is 98.37 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD16+ to those that are HLA-DR+ is 63.21 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD31+ to those that are HLA-DR+ is 69.14 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD29+ to those that are HLA-DR+ is 86.61 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD45+ to those that are HLA-DR+ is 61.73 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD4+ to those that are HLA-DR+ is 65.55 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD68+ to those that are HLA-DR+ is 78.16 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD8A+ to those that are HLA-DR+ is 33.64 times higher in cohort 2 than in cohort 1.
On average, the ratio of the number of cells that are CD3+ to those that are HLA-DR+ is 40.38 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are ICOS+ to those that are PDL1+ is 1.49 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are PDL1+ to those that are ICOS+ is 1.29 times higher in cohort 2 than in cohort 1.

On average, the ratio of the number of cells that are ICOS+ to those that are LAG3+ is 1.41 times higher in cohort 1 than in cohort 2.
On average, the ratio of the number of cells that are LAG3+ to those that are ICOS+ is 1.27 times higher in cohort 2 than in cohort 1.

The above due to outliers.


# One phenotype proximity to itself

## T regs
The average value of the proximity score for phenotype(s) T regulatory cells is 1.39 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) T regulatory cells is 1.64 times higher in cohort 2 than in cohort 1.

## T cells wrt antigen presentation and helper vs. cytotoxic
The average value of the proximity score for phenotype(s) Naive T helper cell is 1.43 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) T helper cell antigen-experienced is 12.43 times higher in cohort 2 than in cohort 1.

The average value of the proximity score for phenotype(s) Naive cytotoxic T cell is 1.59 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) Cytotoxic T cell antigen-experienced is 3.60 times higher in cohort 1 than in cohort 2.

## Macrophage/monocyte
The average value of the proximity score for phenotype(s) Lineage including monocyte is 1.27 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) Lineage including monocyte is 1.42 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) Lineage including macrophage is 1.58 times higher in cohort 1 than in cohort 2.

## B cells
The average value of the proximity score for phenotype(s) B cells is 1.19 times higher in cohort 2 than in cohort 1.
The average value of the spatial autocorrelation score for phenotype(s) B cells is 12.11 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) B cells is 6.51 times higher in cohort 1 than in cohort 2.


# Second pass
The average value of the neighborhood enrichment score for phenotype(s) CD3+ CD45RO+ is 1138.81 times higher in cohort 1 than in cohort 2.
The average value of the ripley score for phenotype(s) CD3+ CD45RO+ is 2.48 times higher in cohort 1 than in cohort 2.

The average value of the neighborhood enrichment score for phenotype(s) CD45RO+, Melanoma is 1.27 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) CD45RA+, Melanoma is 2.06 times higher in cohort 2 than in cohort 1.

Poor p-values:
The average value of the proximity score for phenotype(s) CD3+ CD45RO+ is 1.28 times higher in cohort 1 than in cohort 2.
The average value of the proximity score for phenotype(s) CD45RO+, Melanoma is 1.35 times higher in cohort 2 than in cohort 1.


# Two phenotype proximity, to another
The average value of the proximity score for phenotype(s) Naive cytotoxic T cell, T regulatory cells is 2.40 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) Naive cytotoxic T cell, T regulatory cells is 1.83 times higher in cohort 2 than in cohort 1.

The average value of the neighborhood enrichment score for phenotype(s) Cytotoxic T cell antigen-experienced, T regulatory cells is 2.71 times higher in cohort 1 than in cohort 2.
The average value of the proximity score for phenotype(s) Lineage including macrophage, T regulatory cells is 1.57 times higher in cohort 2 than in cohort 1.
The average value of the proximity score for phenotype(s) Lineage including monocyte, T regulatory cells is 1.47 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) Lineage including monocyte, T regulatory cells is 1.42 times higher in cohort 2 than in cohort 1.

The average value of the proximity score for phenotype(s) Naive cytotoxic T cell, T helper cell antigen-experienced is 2.50 times higher in cohort 1 than in cohort 2.

The average value of the proximity score for phenotype(s) Lineage including macrophage, Cytotoxic T cell antigen-experienced is 1.43 times higher in cohort 2 than in cohort 1.
The average value of the proximity score for phenotype(s) Lineage including monocyte, Cytotoxic T cell antigen-experienced is 1.57 times higher in cohort 2 than in cohort 1.

The average value of the neighborhood enrichment score for phenotype(s) Cytotoxic T cell antigen-experienced, Naive cytotoxic T cell is 2.00 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) Lineage including monocyte, Cytotoxic T cell antigen-experienced is 1.57 times higher in cohort 1 than in cohort 2.

The average value of the proximity score for phenotype(s) Lineage including macrophage, B cells is 1.34 times higher in cohort 2 than in cohort 1.
The average value of the proximity score for phenotype(s) Lineage including monocyte, B cells is 1.57 times higher in cohort 2 than in cohort 1.
The average value of the neighborhood enrichment score for phenotype(s) Lineage including monocyte, B cells is 3.69 times higher in cohort 1 than in cohort 2.
The average value of the neighborhood enrichment score for phenotype(s) Lineage including macrophage, B cells is 10.03 times higher in cohort 1 than in cohort 2.

Tc.ae, patterned:
2 04RD
1 08BL
1 12RD
2 25RD
1 26BL
2 16BL
2 34RD
1 40RD nondense yet patterned
2 42RD nondense yet patterned *

Not:
2 24RD
1 22RD
1 39RD
1 41BL dense yet not patterned *

Ambiguous (separation of regions):
21RD
19BL


spatial proteomics, head and neck squamous cell carcinoma, 2023
https://academic.oup.com/bioinformatics/article/39/Supplement_1/i140/7210468

imc, brain tumors, 2023
https://www.nature.com/articles/s41586-022-05680-3

mpif, bone marrows, 2023
https://www.sciencedirect.com/science/article/pii/S0006497123024084

imc, non-small cell lung cancer, 2024
https://www.cell.com/cancer-cell/pdf/S1535-6108(23)00449-X.pdf

O
O

spatial proteomics, head and neck squamous cell carcinoma, 2023
imc, brain tumors, 2023
mpif, bone marrows, 2023
imc, non-small cell lung cancer, 2024
